apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Wembira-DT 250 Tablet
  3. Wembira-DT 250 Tablet Substitute

Wembira-DT 250 Tablet Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

ABIRATERONE-250MG

Uses:

Wembira-DT 250 Tablet is used in the treatment of prostate cancer. The detailed uses of Wembira-DT 250 Tablet are as follows:<br/>• Treats advanced prostate cancer: Wembira-DT 250 Tablet lowers levels of certain hormones (androgens) that fuel the growth of prostate cancer cells.<br/>• Slows cancer progression: Wembira-DT 250 Tablet helps delay the spread and worsening of prostate cancer.<br/>• Improves overall management of prostate cancer: Wembira-DT 250 Tablet is often used along with other medicines to enhance treatment effectiveness.<br/>

Medicinal Benefits:

Wembira-DT 250 Tablet belongs to the group of medicines called androgen biosynthesis inhibitors, indicated in combination with prednisone or prednisolone to treat prostate cancer in adult men that have spread to other body parts. Wembira-DT 250 Tablet contains ‘Abiraterone’ that works by stopping the body from making testosterone, thereby slowing the growth of prostate cancer. It is indicated in patients with metastatic castration-resistant prostate cancer (CRPC) who have received prior chemotherapy containing docetaxel and metastatic high-risk castration-sensitive prostate cancer (CSPC). Wembira-DT 250 Tablet is prescribed in the early stages of the disease, where it is still responding to hormone therapy. It is used with androgen deprivation therapy (a treatment that lowers testosterone).

FAQs

Wembira-DT 250 Tablet is used to treat Prostate cancer.

Wembira-DT 250 Tablet works by stopping the body from making testosterone, thereby slowing the growth of prostate cancer.

Prednisolone/prednisone is prescribed along with Wembira-DT 250 Tablet to lower the chances of getting high blood pressure, fluid retention (having too much water in the body), or low blood potassium levels.

Wembira-DT 250 Tablet should not be given along with Ra-233 (a radioactive isotope used to treat prostate cancer) due to the increased risk of bone fracture or death. If you are prescribed to take Ra-233 following treatment with Wembira-DT 250 Tablet and prednisolone/prednisone, you must wait five days before starting treatment with Ra-233.

No, Wembira-DT 250 Tablet cannot cure prostate cancer. However, it is used to manage advanced or metastatic prostate cancer that works by inhibiting the production of testosterone, thereby preventing the growth and spread of cancer.

No, Wembira-DT 250 Tablet is not a chemotherapy drug. It is a hormone therapy medication, which reduces testosterone levels to help manage prostate cancer.

Yes, Wembira-DT 250 Tablet may affect the liver. Therefore, the doctor may advise regular blood tests to monitor its effects on the liver.

For patients taking Wembira-DT 250 Tablet liver investigations are recommended. However, the frequency may differ for each individual and can be determined by the doctor based on your medical condition.

Wembira-DT 250 Tablet can be taken orally on an empty stomach, either 1 hour before a meal or 2 hours after the meal. Swallow it as a whole with a glass of water. Do not chew or break it.

The side effects of Wembira-DT 250 Tablet include oedema, urinary tract infection, high blood pressure, low blood potassium, and diarrhoea. Consult the doctor if any of these symptoms persist or worsen.